The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The Methodist Hospital Research Institute
BeOne Medicines
Bayer
ViroMissile, Inc.
Arcus Biosciences, Inc.
Rutgers, The State University of New Jersey
AstraZeneca
Tizona Therapeutics, Inc
Essen Biotech
Clasp Therapeutics, Inc.
Eli Lilly and Company
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
Daiichi Sankyo
Eli Lilly and Company
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
OncoNano Medicine, Inc.
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Pittsburgh
University Health Network, Toronto
NeoTX Therapeutics Ltd.
Medtronic - MITG
BicycleTx Limited
BicycleTx Limited
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Rondo Therapeutics
Actym Therapeutics, Inc.
University of Arizona
Shanghai Escugen Biotechnology Co., Ltd
Sahlgrenska University Hospital
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
Cancer Research UK
Toray Industries, Inc
The Netherlands Cancer Institute
Totus Medicines
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
Cancer Research UK
NGM Biopharmaceuticals, Inc